A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy.

Li Yuan Bai,Muh-Hwa Yang,Nai Jung Chiang,Shang Yin Wu,Chen Yuan Lin,Ming-Yu Lien,Jia Hong Chen,Mu Hsin Chang,Ching Yun Hsieh,Ruey-Long Hong,Hsiang-Fong Kao,Ren Hua Ye,Shang Hung Chen,Chin-Fu Hsiao,Li-Tzong Chen,Tsang Wu Liu

A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy.

2021

Li Yuan Bai
Muh-Hwa Yang
Nai Jung Chiang
Shang Yin Wu
Chen Yuan Lin
Ming-Yu Lien
Jia Hong Chen
Mu Hsin Chang
Ching Yun Hsieh
Ruey-Long Hong
Hsiang-Fong Kao
Ren Hua Ye
Shang Hung Chen
Chin-Fu Hsiao
Li-Tzong Chen
Tsang Wu Liu

6025Background: Liposomal irinotecan (nal-IRI) + 5-FU/LV has been approved and used in treating patients with metastatic pancreatic cancer after gemcitabine-based therapy through the NAPOLI-1 study...

Keywords:

Chemoradiotherapy
Chemotherapy
Liposomal Irinotecan
Oncology
Medicine
Esophagus
Internal medicine
Phases of clinical research
Gemcitabine
Fluorouracil
head and neck

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations